[TOP STORY] Have you been putting healthcare into your offshore portfolios?

Loading player...
New investors might opt for Pfizer, with its somewhat better metrics and yield, as well as its access to the mRNA technology, says Gary Booysen from Rand Swiss.
23 Jul 2021 4AM English South Africa Business News · Business

Other recent episodes

Warsh’s first FOMC: What it signals for the road ahead

Zimele Mbanjwa from FNB Wealth & Investments unpacks Absa's trading update. The stock looks cheap, but the market clearly didn't like what it saw. Ruen Naidu from Ninety One discusses what a new Fed chair with a hawkish stance and a structural reform agenda could mean for markets. Sean Neethling…
1 Jul 1AM 21 min

Prosus strategy for Tencent working

Independent analyst Jimmy Moyaha unpacks the Naspers and Prosus results as Takealot delivers an adjusted Ebitda profit – but is the story still all about Tencent? Invicta CEO Steven Joffe joins us to discuss results showing 50% of revenue now comes from offshore operations as tough local trading conditions persist…
30 Jun 1AM 20 min